Samuel Saidu

Samuel Saidu

University of Sierra Leone - Tower Hill / Sierra Leone
Others
AD Scientific Index ID: 4986744
-
person_outline Samuel Saidu's MOST POPULAR ARTICLES
1-) Safety and long-term immunogenicity of the two-dose heterologous Ad26. ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: A combined open-label, non … D Ishola, D Manno, MO Afolabi, B Keshinro, V Bockstal, B Rogers, ... The Lancet Infectious Diseases 22 (1), 97-109, 2022 362022
2-) Safety and immunogenicity of the two-dose heterologous Ad26. ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial MO Afolabi, D Ishola, D Manno, B Keshinro, V Bockstal, B Rogers, ... The Lancet Infectious Diseases 22 (1), 110-122, 2022 322022
3-) How to prevent and address safeguarding concerns in global health research programmes: practice, process and positionality in marginalised spacesB Aktar, W Alam, S Ali, A Awal, M Bayoh, I Chumo, Y Contay, A Conteh, ...BMJ Global Health 5 (5), e002253, 2020142020
4-) The economics of healthcare access: a scoping review on the economic impact of healthcare access for vulnerable urban populations in low-and middle-income countriesNT de Siqueira Filha, J Li, PA Phillips-Howard, Z Quayyum, E Kibuchi, ...International journal for equity in health 21 (1), 191, 2022192022
5-) Covid‐19 response and protracted exclusion of informal settlement residents in Freetown, Sierra LeoneA Conteh, MS Kamara, S Saidu, JM MacarthyIDS Bulletin 52 (1), 95-104, 2021122021